Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as Chemoprevention in NSCLC
NCT01717482Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Oct 2012
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in non-small cell lung cancer (NSCLC), sponsored by Mayo Clinic. Started Oct 2012; status: terminated.
02
Drugs
metformin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01717482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01717482.